Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Biologic and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers.

NCT07852338 is registered in ClinicalTrials.gov with Applied Biologics, LLC as lead sponsor.

NCT NCT07852338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Biologic and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers.
Lead sponsor
Applied Biologics, LLC
Phase
Phase 3
Overall status
Recruiting
Start date
October 8, 2026
Completion date
January 31, 2029
Enrollment
253 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amniotic membrane placental allograft, biologic, diabetic foot ulcer